Evidence map›Paper›PMID 30678190›Full record

ArticleInternational journal of molecular sciences2019

Vasoprotective Functions of High-Density Lipoproteins Relevant to Alzheimer's Disease Are Partially Conserved in Apolipoprotein B-Depleted Plasma.

Emily B Button, Megan Gilmour, Harleen K Cheema, Emma M Martin, Andrew Agbay, Jérôme Robert, Cheryl L Wellington

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Midlife lipid and glucose levels are associated with Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. HDL from an Alzheimer's disease perspective.Current opinion in lipidology · 2019
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Emily B ButtonDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. ebbutton@mail.ubc.ca.ORCID 0000-0003-0390-0867
Megan GilmourDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. meg.gilmour@gmail.com.
Harleen K CheemaDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. harleencheema@hotmail.com.
Emma M MartinDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. emmarie@mail.ubc.ca.
Andrew AgbayDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. andrew.agbay@ubc.ca.
Jérôme RobertDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. jerome.robert@ubc.ca.
Cheryl L WellingtonDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. cheryl.wellington@ubc.ca.
University of British Columbia · CA

Funding

BrightFocus Foundation F14-04413Canadian Institutes of Health Research F15-04425Jack Brown and Family Alzheimer Research Foundation Society F16-00443Weston Brain Institute F18-03242
6 · The paper itself

Abstract

High-density lipoproteins (HDL) are known to have vasoprotective functions in peripheral arteries and many of these functions extend to brain-derived endothelial cells. Importantly, several novel brain-relevant HDL functions have been discovered using brain endothelial cells and in 3D bioengineered human arteries. The cerebrovascular benefits of HDL in healthy humans may partly explain epidemiological evidence suggesting a protective association of circulating HDL levels against Alzheimer's Disease (AD) risk. As several methods exist to prepare HDL from plasma, here we compared cerebrovascular functions relevant to AD using HDL isolated by density gradient ultracentrifugation relative to apoB-depleted plasma prepared by polyethylene-glycol precipitation, a common high-throughput method to evaluate HDL cholesterol efflux capacity in clinical biospecimens. We found that apoB-depleted plasma was functionally equivalent to HDL isolated by ultracentrifugation in terms of its ability to reduce vascular Aβ accumulation, suppress TNFα-induced vascular inflammation and delay Aβ fibrillization. However, only HDL isolated by ultracentrifugation was able to suppress Aβ-induced vascular inflammation, improve Aβ clearance, and induce endothelial nitric oxide production.

Indexed as

AdultAlzheimer DiseaseAmyloid beta-PeptidesApolipoproteins BBioengineeringBlood-Brain BarrierCells, CulturedCerebral Amyloid AngiopathyEndothelial CellsEnzyme-Linked Immunosorbent AssayFemaleHumansInflammationLipoproteins, HDLMaleMonocytesAmyloid beta-PeptidesApolipoproteins BLipoproteins, HDLNitric OxideAlzheimer’s diseaseamyloid beta (Aβ)blood-brain barrier (BBB)cerebral amyloid angiopathy (CAA)cerebrovasculatureendothelial cellhigh-density lipoprotein (HDL)inflammation

Identifiers

PMID30678190
PMCPMC6387156
OpenAlexW2913328437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.